PFBT
IRON icon

Parkside Financial Bank & Trust’s Disc Medicine IRON Stock Holding History

Parkside Financial Bank & Trust’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46K Hold
20
– – ﹤0.01% 2289
2026
Q1 		$1.28K Hold
20
– – ﹤0.01% 2266
2025
Q4 		$1.59K Hold
20
– – ﹤0.01% 2179
2025
Q3 		$1.32K Hold
20
– – ﹤0.01% 2171
2025
Q2 		$1.06K Buy
+20
New +$939 ﹤0.01% 2246

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parkside Financial Bank & Trust's IRON Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Disc Medicine (IRON) position steady in Q2 2026 at 20 shares worth $1.46K. The position accounts for ﹤0.01% of the portfolio, ranked #2289.

Parkside Financial Bank & Trust first reported a position in IRON in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.59K in Q4 2025. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Parkside Financial Bank & Trust held 20 shares of Disc Medicine worth $1.46K as of Q2 2026.
  • Parkside Financial Bank & Trust left its Disc Medicine share count unchanged in Q2 2026.
  • Disc Medicine made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2289 holding.
  • Parkside Financial Bank & Trust first reported a position in Disc Medicine in Q2 2025 and has held it in 5 quarters since.
  • Parkside Financial Bank & Trust's Disc Medicine position peaked at $1.59K in Q4 2025.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.